Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early stage HER2-positive breast cancer
Findings from a large phase III study, ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation), suggest…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
How prostate cancer sufferers can add a year to their lives
Source: Australian Financial Review – Jill Margo. Researchers have extended the lives of men with…
Skin cancer a possible downside of Viagra
Source: SMH – Amy Corderoy Men who use impotence drugs such as Viagra could be…
New experimental wonder drug a cancer buster
Source: Herald Sun – Brigid O’Connell. Victorians with advanced chemotherapy-resistant leukaemia or are too frail…
Astra-Zeneca cancer drug hailed as ‘great white hope’ in fight against illness
Source: The Guardian – Rupert Neate. Drug MEDI4736 fast-tracked to phase-III trials following tests on…
Scientists discover ‘brakes’ to stop cancer-causing ‘car-crashes’ in cells
Cancer Research UK scientists have discovered a new role for a protein that may put…
Water pipe smoking causes significant exposure to nicotine and cancer-causing agents
Young adults who smoked water pipes in hookah bars had elevated levels of nicotine, cotinine,…
‘Blood lab’ inside a mobile phone could detect cancer
Plans to design a smart phone app that can detect leukaemia were recently presented by…
Immunotherapy may work in cancers: study
The success of an adoptive cell therapy in shrinking a woman’s tumours could mark a…
Anti-cancer effect of common industrial solvent discovered in Peter Mac laboratories, heralding world-first clinical trial
Researchers from Melbourne’s Peter MacCallum Cancer Centre have revealed a common solvent, found in domestic,…